AUB
SGMO

Atlantic Union Bankshares’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Atlantic Union Bankshares’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$168 – 1822
2025
Q4 		$168 Hold
400
– – ﹤0.01% 1643
2025
Q3 		$270 Hold
400
– – ﹤0.01% 1580
2025
Q2 		$217 Buy
+400
New +$238 ﹤0.01% 1177

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Atlantic Union Bankshares's SGMO Position: Q1 2026 in Review

Atlantic Union Bankshares sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 400 shares — an estimated $168 sold.

Atlantic Union Bankshares first reported a position in SGMO in Q2 2025 and held it in 3 quarters. The position peaked at $270 in Q3 2025. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Atlantic Union Bankshares reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Atlantic Union Bankshares sold 400 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $168.
  • Atlantic Union Bankshares first reported a position in SANGAMO THERAPEUTICS INC in Q2 2025 and held it in 3 quarters.
  • Atlantic Union Bankshares's SANGAMO THERAPEUTICS INC position peaked at $270 in Q3 2025.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.